small molecule

HYDROXYCHLOROQUINE SULFATE

HYDROXYCHLOROQUINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYDROXYCHLOROQUINE SULFATE
Active ingredientHYDROXYCHLOROQUINE SULFATE
Strength200MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2018
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.